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Endogenous ouabain: Role in the pathogenesis of hypertension. Sub-
stantial evidence implicates impaired renal excretion of sodium as the
major culprit in the pathogenesis of hypertension. The key question is:
How does the impairment of Na excretion lead to increased peripheral
vascular resistance and elevation of the blood pressure? Here we describe
the evidence that elevated levels of a recently-discovered adrenal cortical
hormone, endogenous ouabain, plays a central role in this process. This
hormone inhibits the Na pump and raises intracellular Nat Then, as a
result of Na/Ca exchange, cytosolic Ca2 and, more importantly, intracel-
lular Stores of Ca2, are increased in vascular smooth muscle (VSM),
vasomotor neurons, and endothelial cells, as well as in many other types of
cells. Consequently, these cells become hyper-responsive because the
cytosolic Ca2 transients induced by cell activation are enhanced. The
synergy of augmented sympathetic neuron transmitter release and aug-
mented VSM cell responsiveness may account for the increased arterial
tone and peripheral vascular resistance that is the hallmark of hyperten-
sion.
In his classic monograph, The Kidney, Homer Smith [1] devoted
a full chapter to the subject of "Essential Hypertension." He
wrote that the enhanced arterial tone with increased total periph-
eral vascular resistance (TPR), the hallmark of essential hyper-
tension, "has a functional origin." Nevertheless, due to the paucity
of data then available, he was unable to draw firm conclusions
about the pathogenesis of essential hypertension.
In the ensuing decade, a number of new studies, some of which
involved the then recently-discovered mineralocorticoids, led
Borst and Borst-de Geus [2] to re-examine the mechanisms
responsible for the elevation of blood pressure. They suggested
that "hypertension is part of a homoeostatic reaction to deficient
renal sodium output." Subsequently, Guyton and his colleagues [3]
re-emphasized the "overriding dominance of the kidneys" in the
pathogenesis of hypertension. They concluded that "All long-term
arterial pressure regulation must involve the balance between intake
and output of water and salt and almost invariably involves the
kidneys."
Coleman and Guyton [4] examined the hemodynamic changes
that resulted from chronic salt and water retention and plasma
volume expansion. They observed an initial rise in blood pressure
due to increased cardiac output (CO) with a normal TPR. After
several days of maintained volume expansion, however, CO
declined and TPR increased to maintain the elevated blood
pressure. This would be expected to induce a pressure natriuresis
to help maintain salt balance and plasma volume. The shift from
a high CO to a high TPR has been referred to as "autoregulation"
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[4, 51. The view that the increased TPR of essential hypertension
is a consequence of "autoregulation" does not, however, shed
light on the precise mechanisms that underlie these hemodynamic
changes.
The primary defect in the pathogenesis of essential hyperten-
sion thus appears to be an inability of the kidneys to handle the
salt load with which they are faced in the presence of a normal
blood pressure [2, 3, 6, 7]. Blood pressure therefore rises along the
renal function curve, until the induced pressure natriuresis en-
ables the kidneys to balance salt excretion with salt intake [2, 3, 5].
Endogenous ouabain and the pathogenesis of hypertension
In an effort to explain the origin of the increased TPR on the
basis of functional changes, it was suggested [8] that the enhanced
vascular tone might be the direct result of a slight excess of Ca2
in the vascular smooth muscle (VSM) cells. The problem, then,
was how to link this alteration in Ca2 homeostasis to a primary
defect in renal excretion of sodium. One proposed solution to this
dilemma was the plasma membrane Na/Ca exchanger [8], which is
a unique link between Na and Ca2 metabolism and, thus,
between Na and VSM contraction. This raised the possibility
that the increased intracellular Ca2 might be a secondary
consequence of a slightly increased intracellular Na concentra-
tion, To explain the increased the presence of
elevated levels of a circulating endogenous digitalis-like substance
was postulated (Fig. 1) [8, 9] . These concepts were later expanded
to include the possibility that similar ionic alterations in vasomo-
tor neurons and/or in endothelial cells might contribute to the
enhanced vasoconstriction (Fig. 1, lower right quadrant, and see
below) [10, 11].
In the nearly two decades since these ideas were first put forth,
several key features of the hypothesis have been directly tested.
Most importantly, the critical missing link, the endogenous digi-
talis-like substance was purified from human plasma. Astonish-
ingly, this substance was identified as either identical to, or a
closely-related isomer of, the plant-derived cardiac glycoside,
ouabain [12]. The endogenous ouabain co-chromatographs with
plant ouabain, and has an identical molecular weight and very
similar mass spectroscopic properties [12, 13]. The presence of an
endogenous ouabain-like compound in mammals has been con-
firmed by several investigators [14—18].
Endogenous ouabain and plant ouabain (hereafter, "ouabain")
have virtually identical vasotonic and cardiotonic properties [19],
and comparable ability to inhibit the Na pump [12]. Even in the
rat (which is widely recognized as "insensitive" to cardiotonic
steroids) both neural tissue [20] and VSM [21] are sensitive to
nanomolar concentrations of ouabain. This can be explained by
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Fig. 1. Diagram showing some of the major feed-back loops that help prevent plasma volume expansion when excessive NaF is ingested, relative to the kidney's
innate ability to excrete the Na + load. Signs (+) and (—) are positive and negative feedback loops, respectively. Abbreviations are: ADH, antidiuretic
hormone; ANP, atrial natriuretic peptides; [Na '] and [Ca21, intracellular (cytosolic) Na and Ca2 concentrations, respectively. The diagram is
self-explanatory, but further descriptive information is provided in the text and in [11]. From [111 with permission of the American Physiological Society.
the presence of some Na pump molecules with a subunits that
are highly ouabain-sensitive (that is, the a3 isoform) [22, 23].
Endogenous ouabain is found in high concentration in the
adrenal glands of mammals [12, 14, 15]. It is synthesized and
secreted by adrenal cortical cells in culture [24]. Indeed, a new
syndrome has been recognized in a patient with elevated plasma
endogenous ouabain and hypertension associated with an adre-
nocortical tumor that contained an exceptionally large amount of
ouabain (that is, a "ouabainoma") [25].
The physiological stimulus for secretion is uncertain. Increased
dietary salt raises plasma endogenous ouabain levels in humans
[26]. There is a question, however, about whether the secretion is
mediated by increased plasma volume expansion [27]. In human
congestive heart failure, plasma endogenous ouabain levels are
inversely correlated with the cardiac index [28].
The hypothesis diagramed in Figure 1 leads to the prediction
that ouabain ought to induce hypertension. This prediction has
been directly tested, and the results are unequivocal: Chronic
parenteral administration of ouabain to normal rats induces a
sustained hypertension [29, 30]. Moreover, about 40% of human
subjects with essential hypertension have plasma endogenous
ouabain levels more than two 5D5 above the normal mean of 0.5
nM, and blood pressure is directly correlated with plasma endog-
enous ouabain [31, 321.
Taken together, these findings validate several key elements of
the hypothesis illustrated in Figure 1. A critical unresolved issue,
however, has been: What is the mechanism by which ouabain
elevates blood pressure? We will focus on this issue in the ensuing
discussion.
How does ouabain elevate blood pressure?
As described above, slight inhibition of the Na pump by
ouabain would he expected to increase [Na] slightly. This
should, via the Na/Ca exchange, concomitantly raise the cytosolic
Ca2 concentration, [Ca2I, in VSM cells. Most of the intra-
cellular Ca2 in these cells is sequestered in the sarcoplasmic
reticulum (SR), where it is concentrated 1,000-fold or more. Thus,
a sustained small increase in [Ca2]51 should induce a large
increase in SR Ca2 [11]. In other words, the SR can be expected
to amplify the (indirect) effect of the ouabain on cell Ca2t Then,
because much of the Ca2 that triggers contraction during VSM
activation comes from the SR, these cells with increased SR Ca2
([Ca2]SR) should contract much more vigorously in response to
activation by neuroeffectors such as noradrenaline, This postu-
lated sequence of events (ouabain — [Na] — I [CaI —I [Ca2]. — I I VSM cell responsiveness) can be directly
tested.
The presence of a Na/Ca exchanger in the plasma membrane of
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Fig. 2. Effects of ouabain on [Na *J and [Ca2 in rat aortic myocytes. A. SBFI loaded cells were incubated in PSS with 1 mM ouabain to measure
the time course of changes in The data correspond to the mean values for 19 cells. B. Fura-2 loaded cells were incubated in PSS in the absence
or presence of 1 mtvi ouabain, as indicated. Ca2 release was evoked by 5 /.LM CPA (in Ca2-free PSS). Data correspond to mean values for 14 cells from
a representative experiment. C. Graph of increases in resting [Ca2I and CPA-evoked Ca2 transients graphed as a function of The abscissa
values were obtained from A; ordinate values were obtained from experiments similar to the one shown in B, in which the duration of exposure to
ouabain was varied. Resting ICa21, corresponds to the increase in [Ca21, after a 0,5, 10 or 15 minutes exposure to ouabain, relative to the [Ca2I
before the first (control) response to CPA. CPA-evoked [Ca2I corresponds to the increase in the amplitude of the second Ca2 transient (after 0,
5, 10 or 15 mm in ouabain) relative to the first (control) response to CPA. From [37] with permission.
VSM cells, a central feature of this hypothesis, has been the
subject of controversy. Recently, this questionable point was
resolved by the direct identification of the exchanger gene,
mRNA, and protein in VSM cells by immunocytochemical and
molecular biological methods [33, 34].
can be measured with the Na-sensitive fluorescent
indicator, SBFI [35]. As illustrated in Figure 2A, treatment with
ouabain causes [Na] to rise in SBFI-loaded VSM cells.
Ouabain also causes [Ca2jcyt to rise, as demonstrated in cells
loaded with the Ca2 indicator, fura-2; however, the rise in resting
[Ca21 is relatively small, even in presence of high doses of
ouabain (Figs. 2 B, C and 3) [36, 37]. The rise in [Ca2] is
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Fig. 3. Effect of ouabain on serotonin (5-HT)-evoked Ca2 transients in
cultured A7r5 cells. [Ca2],, was measured in fura-2 loaded A7r5 cells
(derived from fetal rat aorta). The cells were superfused with standard
physiological salt solution (PSS). As indicated by the appropriately-
labeled bars below the graph, PSS was replaced by Ca-free PSS containing
0.5 mt EGTA one minute before introduction of 5-HT; note the rapid
drop in [Ca2]0, at this time. Subsequent addition of 1 jM 5-HT to the
Ca-free PSS for 45 seconds (indicated by the short upper bars) induced a
rapid, transient rise in [Ca2]. Ouabain (1 mM) was added to the PSS
after recovery from the first Ca2 transient. This caused [Ca21cyt to rise
slightly in the unstimulated cells; however, it greatly increased the
amplitude of the subsequent 5-HT evoked Ca2 transient. The data are
the means from 12 cells. From [361 with permission.
attenuated by the rapid sequestration of Ca2 in the SR as well as
by Ca2 extrusion via the plasma membrane ATP-driven Ca2
pump.
The rise in Ca2 within the intracellular stores can be visualized
directly in cells loaded with the Ca2-sensitive fluorochrome,
chlortetracycline (CTC) [36, 38]. CTC is lipophilic, and is concen-
trated in the intracellular (such as SR) membranes. It has a
relatively low affinity for Ca2 compared to fura-2 (Kd for the
Ca2-CTC complex 50 IIM vs. 0.25 LLM for Ca2-fura-2), and is
thus suitable for measurements of Ca2 within the intracellular
stores and not in the cytosol. CTC exhibits increased fluorescence
when [Ca2]SR increases during ouabain treatment (Fig. 4).
Evidence that this is SR Ca2 is provided by the fact that the SR
Ca2 pump inhibitor, thapsigargin (TG), which depletes SR Ca2
[39], reduces the fluorescence (Fig. 4 A, B).
Complementary evidence that ouabain increases SR Ca2 is
shown in Figure 2B. In these fura-2 loaded cells, we see that the
rise in [Ca2], (that is, the cytosolic Ca2 transient), evoked by
cyclopiazonic acid (CPA; which also blocks the SR Ca2 pump
[39]), is greatly augmented after a 15 minute exposure to 1 mM
ouabain. The increase in the CPA-evoked Ca2 transient as well
as the increase in resting [Ca2] are graphed as a function of
[NaJ in Figure 2C. It is apparent that a large increase in the
evoked Ca2 transient (reflecting the increase in SR Ca2) is
associated with only a small increase in resting [Ca2], as
anticipated (see above). Ouabain also greatly augments the Ca2
transient evoked by the physiologic vasoconstrictor, serotonin
(5-HT) (Fig. 3). These 5-HT evoked Ca2 transients reflect only
5-HT the relative SR Ca2 content (and not Ca2 entry) because
extracellular Ca2 was removed 30 seconds before the 5-HT was
added.
The preceding experiments (Figs. 2—4) were all carried out with
very high (non-physiological) concentrations of ouabain. To ad-
dress this problem, some experiments were carried out with much
lower doses of ouabain [21]. The experiment of Figure 5 shows
that even 1 nM ouabain reversibly augments caffeine-evoked
contractions in rat mesenteric artery. Comparable results have
been obtained in rat tail artery and human subcutaneous artery
(Bova and Blaustein, unpublished observations).
This functional relationship between the plasma membrane
Na/Ca exchanger and SR has a structural correlate. The ex-
Ca free changer molecules are distributed in clusters arranged in reticular
patterns on the VSM cell surface [33] that are co-localized with
underlying (junctional) SR [37]. This raises the possibility that a
major role of the Na/Ca exchanger is to modulate the Ca2
content of the SR stores via a restricted portion of the cytosol that
lies between the plasma membrane and the junctional SR.
Which cell types contribute to the augmented vascular tone?
It is essential to note that the ouabain-augmented responses
illustrated by the data in Figures 2 to 4 are not limited to the VSM
cells. Comparable augmentation of other Ca2-dependent physi-
ological processes can be anticipated in most other types of cells
in the body, which also have a plasma membrane Na pump, a
plasma membrane Na/Ca exchanger, and endoplasmic reticulum
(ER) Ca2 stores. Thus, vasomotor neurons and endothelial cells
would also be expected to increase their ER Ca2 stores, and to
exhibit a heightened responsiveness, when they are treated with
ouabain (Fig. 1). For example, ouabain antagonizes endothelium-
dependent relaxation of VSM [40], and also augments synaptic
transmission [41]. This leaves open the question of whether the
elevated plasma endogenous ouabain in hypertensive subjects acts
primarily on the VSM cells or on the vasomotor neurons and/or
endothelial cells, to effect the elevation of blood pressure. A likely
possibility, as in Figure 1 (lower right quadrant), is that the
synergistic responses to ouabain in all of these cell types (and
perhaps also in the central neurons that control blood pressure)
culminate in the increased arterial tone and hypertension. Given
the very steep relationship between blood vessel radius (r) and
TPR (that is, resistance oc 1/r4), relatively slight changes in
contractile activation of the myocytes in the small resistance
vessels should have a substantial effect on the blood pressure.
Thus, the hypothesis outlined in Figure 1 provides a specific
mechanism to account for the "functional origin" of the increased
TPR in essential hypertension mentioned by Homer Smith [1].
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AFig. 5. Effect of low-dose ouabain on caffeine-evoked contraction amplitude
in a ring of rat small mesenteric artery. Isometric tension was measured in
a third order branch of the mesenteric artery. Initially (A), the tissue was
bathed with standard PSS containing 3 >< 10—8 M phenylephrine (PE) to
increase the resting tone slightly; this PE concentration negligibly affected
the resting tension. The standard PSS (with PE) was replaced by a similar
solution containing caffeine (Caf, 10 mM) for 45 seconds periods as
indicated by the short black bars. During the 50 minutes period indicated
by the long black bar, the standard physiological salt solution was replaced
by a similar PSS containing iO M ouabain as well as the PE; at the end
of this period, the original, ouabain-free PSS containing PE was restored.
Note that the amplitude of the Caf-evoked contractions increased sub-
stantially in the presence of this low dose of ouabain, and gradually fell
when the ouabain was washed out. From [11] with permission (and see
[21]).
Note added in proof
Recently Zhao et al reported that the endogenous ouabain-like com-
pound purified by Hamlyn et al [12] is an isomer of plant ouabain.
ZHAO N, Lo L-C, BEROVA N, NAsANIsHI K, TYMIAK AA, LUDENS JH,
HAUPERT GT JE: Na, K-ATPase inhibitors from bovine hypothalamus and
human plasma are different from ouabain: Nanogram scale CD structural
analysis. Biochemistry 34:9893—9896, 1995
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